4.6 Article

Pharmacotherapy for the Core Symptoms in Autistic Disorder: Current Status of the Research

期刊

DRUGS
卷 73, 期 4, 页码 303-314

出版社

ADIS INT LTD
DOI: 10.1007/s40265-013-0021-7

关键词

-

资金

  1. National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH)
  2. NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002868] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The current review covers extant literature on pharmacotherapy for core symptoms of autism. The core symptoms of autism include impairments in social interaction and communication, as well as the presence of restricted and repetitive behaviors. There are no known efficacious treatments for the core social symptoms, although effects on repetitive behaviors are indicated with some data. While studies of fenfluramine, secretin, opiates, and mood stabilizers generally find no effect, mixed results suggest more research is needed on antidepressants and atypical antipsychotics. Newer lines of research, including cholinergic and glutamatergic agents and oxytocin, will be of considerable interest in the future. However, research on the treatment of core symptoms is plagued by limitations in study design, statistical power, and other issues inherent to the study of treatments for autism (e.g., heterogeneity of the disorder) that continue to prevent the elucidation of efficacious treatments.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据